Palvella Therapeutics, Inc. Stock Repurchase Program, Number of Shares Authorized to be Repurchased
Palvella Therapeutics, Inc. (PVLA) had Stock Repurchase Program, Number of Shares Authorized to be Repurchased of 542.36 thousand shares as of 2015-12-31, per its 10-K filed 2016-03-23.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased · last filed 2016-03-23
- 2015-12-31: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 542.36K shares.
- 2014-12-31: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 542.36K shares.
| Period end | Stock Repurchase Program, Number of Shares Authorized to be Repurchased |
|---|---|
| 2015-12-31 | 542.36K shares 10-K · filed 2016-03-23 |
| 2014-12-31 | 542.36K shares 10-Q · filed 2015-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |